Literature DB >> 26026111

Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma.

Georg C Hutterer1, Daniel Krieger2, Edvin Mrsic2, Kristof Pohlmann2, Angelika Bezan3, Tatjana Stojakovic4, Karl Pummer2, Richard Zigeuner2, Martin Pichler5.   

Abstract

BACKGROUND: To validate the potential prognostic significance of preoperatively assessed inflammatory parameters leucocytosis, thrombocytosis and anemia in patients with non-metastatic renal cell carcinoma (RCC).
MATERIALS AND METHODS: We retrospectively evaluated a cohort comprising 736 consecutive patients with non-metastatic RCC, operated on between 2004 and 2012 with curative radical or partial nephrectomy at a single tertiary academic centre. Laboratory parameters were assessed within one week before surgical intervention. Patients were categorized using laboratory parameter cut-off values according to receiver operating characteristics (ROC) analyses. Cancer-specific survival (CSS) was assessed using the Kaplan-Meier method. To evaluate the potential prognostic significance of the preoperative laboratory parameters, multivariate Cox regression models were applied.
RESULTS: Multivariable analysis identified preoperative thrombocytosis (≥285,000/μl) as an independent prognostic factor for CSS (Hazard ratio=2.28, 95% confidence interval=1.24-4.20, p=0.008).
CONCLUSION: Regarding CSS, an elevated preoperative platelet count represented an independent prognostic factor of poor survival. Our findings strengthen the potential prognostic significance of preoperative thrombocytosis in patients with non-metastatic RCC. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Anemia; leucocytosis; prognosis; renal cell carcinoma; thrombocytosis

Mesh:

Year:  2015        PMID: 26026111

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.

Authors:  Jin Wang; Jinglei Qu; Zhi Li; Xiaofang Che; Jing Liu; Yuee Teng; Bo Jin; Mingfang Zhao; Yunpeng Liu; Xiujuan Qu
Journal:  J Clin Lab Anal       Date:  2017-02-26       Impact factor: 2.352

2.  Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization.

Authors:  Fei Luo; Ya-Shen Wang; Yan-Hui Su; Zhi-Hua Zhang; Hong-Hong Sun; Jian Li
Journal:  Lasers Med Sci       Date:  2016-12-24       Impact factor: 3.161

3.  The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

Authors:  Jung Ki Jo; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh
Journal:  Int Urol Nephrol       Date:  2016-01-25       Impact factor: 2.370

4.  Can we Predict Preoperative Tumor Aggressivity with Hemogram Parameters in Renal Cell Carcinoma? a Novel Calculation Method.

Authors:  Murat Uçar; Sedat Soyupek; Taylan Oksay; Alper Özorak; Ali Akkoç; Murat Topçuoğlu; Murat Demir; Alim Koşar
Journal:  J Med Syst       Date:  2019-12-10       Impact factor: 4.460

5.  Prognostic value of inflammation-based scores in patients with osteosarcoma.

Authors:  Bangjian Liu; Yujing Huang; Yuanjue Sun; Jianjun Zhang; Yang Yao; Zan Shen; Dongxi Xiang; Aina He
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

6.  Prognostic implications of preoperative anemia in urothelial carcinoma: A meta-analysis.

Authors:  Fei Luo; Ya-Shen Wang; Yan-Hui Su; Zhi-Hua Zhang; Hong-Hong Sun; Jian Li
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

7.  Assessment of hypercoagulability using thromboelastography predicts advanced status in renal cell carcinoma.

Authors:  Xun Wang; An Shi; Jiwei Huang; Yonghui Chen; Wei Xue; Jin Zhang
Journal:  J Clin Lab Anal       Date:  2019-08-22       Impact factor: 2.352

8.  Preoperative anaemia and thrombocytosis predict adverse prognosis in non-metastatic renal cell carcinoma with tumour thrombus.

Authors:  Ruotao Xiao; Chuxiao Xu; Wei He; Lei Liu; Hongxian Zhang; Cheng Liu; Lulin Ma
Journal:  BMC Urol       Date:  2021-02-27       Impact factor: 2.264

9.  Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.

Authors:  Toshiro Kinouchi; Motohide Uemura; Cong Wang; Yu Ishizuya; Yoshiyuki Yamamoto; Takuji Hayashi; Kyosuke Matsuzaki; Wataru Nakata; Takahiro Yoshida; Kentaro Jingushi; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Kazutoshi Fujita; Ryoichi Imamura; Yuko Ueda; Kaori Kitae; Kazutake Tsujikawa; Norio Nonomura
Journal:  Cancer Sci       Date:  2017-10-25       Impact factor: 6.716

10.  Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.

Authors:  Xunlei Zhang; Wenjing Zhao; Yang Yu; Xue Qi; Li Song; Chenfei Zhang; Guoxing Li; Lei Yang
Journal:  World J Surg Oncol       Date:  2020-07-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.